Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ · Healthcare
Arcturus Therapeutics Holdings Inc. Revenue 2018–2025
Arcturus Therapeutics Holdings Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Arcturus Therapeutics Holdings Inc. revenue for the quarter ending March 31, 2026 was 2.1 M, a 92.99% decrease year-over-year.
- Arcturus Therapeutics Holdings Inc. revenue for the twelve months ending March 31, 2026 was 76.9 M, a 55.98% decrease year-over-year.
- Arcturus Therapeutics Holdings Inc. annual revenue for 2025 was 82.0 M, a 46.14% decrease from 2024.
- Arcturus Therapeutics Holdings Inc. annual revenue for 2024 was 152.3 M, a 8.69% decrease from 2023.
- Arcturus Therapeutics Holdings Inc. annual revenue for 2023 was 166.8 M, a 19.03% decrease from 2022.
- Arcturus Therapeutics Holdings Inc. annual revenue for 2022 was 206.0 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Arcturus Therapeutics Holdings Inc. Market Cap — FAQ
Arcturus Therapeutics Holdings Inc. (ARCT) market cap over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARCT's market cap history?
The chart and table above show Arcturus Therapeutics Holdings Inc.'s market cap by year and by quarter, including the growth rate.